Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
暂无分享,去创建一个
B. Neyns | R. Buyl | S. Wilgenhof | G. Meersseman | I. Chevolet | M. Schreuer | Sari van Den Herrewegen | B. Jacobs | T. Seremet | G. Maertens | Y. Jansen | A. Bott